Gene News and Research

Latest Gene News and Research

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers at The University of Texas MD Anderson Cancer Center report in the journal Leukemia.

13 Jul 2017

Study demonstrates potential nanoparticle-based therapeutic strategy for deadly brain tumors

Early phase Northwestern Medicine research has demonstrated a potential new therapeutic strategy for treating deadly glioblastoma brain tumors.

13 Jul 2017

FDA advisory committee recommends Novartis' CAR-T therapy for young leukemia patients

Today the FDA's Oncologic Drugs Advisory Committee, an independent panel of experts, voted unanimously to recommend to the FDA approval of Novartis' experimental CAR-T therapy called Tisagenlecleucel, also known as CTL019.

13 Jul 2017

MPFI researchers reveal new technique to probe function of cerebellar interneurons

The cerebellum is an area of brain at the back of your head involved in movement. Its neuronal circuitry is relatively simple compared to other areas, but scientists still have a lot left to learn regarding its role in motor control and motor learning.

13 Jul 2017

New partnership to advance novel airway-delivered gene therapy for treating pulmonary hypertension

Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure.

13 Jul 2017

E-Scape Bio announces extension of funding to develop novel drug for Alzheimer's disease

E-Scape Bio announced an extension of its Series A funding to a total of $63 million. Created as a spin-off from research conducted at the Gladstone Institutes, E-Scape Bio is a biopharmaceutical company with a mission to develop new therapies to treat neurodegenerative disorders such as Alzheimer's disease.

12 Jul 2017

Computational analysis of open-access data points to new ways of using drugs

A research team led by scientists at UC San Francisco has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.

12 Jul 2017

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.

12 Jul 2017

Study shows potential of whole genome sequencing and AI to help clinicians scale precision oncology

In a study published today in the July 11, 2017 issue of Neurology Genetics, an official journal of the American Academy of Neurology, researchers at the New York Genome Center, The Rockefeller University and other NYGC member institutions, and IBM have illustrated the potential of IBM Watson for Genomics to analyze complex genomic data from state-of-the-art DNA sequencing of whole genomes.

11 Jul 2017

Study links heart failure biomarker to tumors observed in rare genetic diseases

Galectin-3, a protein that promotes cancer cell growth and is used as a biomarker for heart failure, has been linked to tumors observed in two rare genetic diseases, according to a study published July 11, 2017, in eLife.

11 Jul 2017

Modified skin biopsy could provide faster and better diagnosis of inherited, fatal nerve disease

Johns Hopkins physicians report success in a small study of a modified skin biopsy that hastens the earlier diagnosis of an inherited and progressively fatal nerve disease and seems to offer a clearer view of the disorder's severity and progression.

11 Jul 2017

Researchers discover basic genetic mechanism that causes congenital myotonic dystrophy

For years, the underlying process that causes a debilitating muscle disorder in infants and young children has been largely unknown.

11 Jul 2017

Synthetic compound that reads mitochondrial DNA could lead to treatments for nerve, muscle diseases

For the first time, a synthetic compound has been made that can bind to DNA in the cells' energy powerhouses, suppressing a gene associated with nerve and muscle disease.

11 Jul 2017

Scientists find single protein that controls genes essential for spermatogenesis

Scientists have found a single protein--Ptbp2--controls a network of over 200 genes central to how developing sperm move and communicate. The protein works by regulating how RNA is processed during each stage of sperm development.

10 Jul 2017

Study uncovers new genetic variants for lung cancer risk

A new study conducted by an international team of lung cancer researchers, including Professor John Field from the University of Liverpool, have identified new genetic variants for lung cancer risk.

10 Jul 2017

Scientists reveal role of cellular prion protein in development of NF2-related tumors

New research published today, 10th July 2017, online in the journal Oncogene could offer hope to the thousands of, mainly young, people affected by the hereditary condition Neurofibromatosis 2 (NF2).

10 Jul 2017

UCLA study: Changes in brain regions may hold key to why some people prefer order and certainty

Why do some people prefer stable, predictable lives while others prefer frequent changes? Why do some people make rational decisions and others, impulsive and reckless ones? UCLA behavioral neuroscientists have identified changes in two brain regions that may hold answers to these questions.

10 Jul 2017

Gene News and Research

Latest Gene News and Research

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Study demonstrates potential nanoparticle-based therapeutic strategy for deadly brain tumors

FDA advisory committee recommends Novartis' CAR-T therapy for young leukemia patients

MPFI researchers reveal new technique to probe function of cerebellar interneurons

New partnership to advance novel airway-delivered gene therapy for treating pulmonary hypertension

E-Scape Bio announces extension of funding to develop novel drug for Alzheimer's disease

Computational analysis of open-access data points to new ways of using drugs

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

Study shows potential of whole genome sequencing and AI to help clinicians scale precision oncology

Study links heart failure biomarker to tumors observed in rare genetic diseases

Modified skin biopsy could provide faster and better diagnosis of inherited, fatal nerve disease

Researchers discover basic genetic mechanism that causes congenital myotonic dystrophy

Synthetic compound that reads mitochondrial DNA could lead to treatments for nerve, muscle diseases

Scientists find single protein that controls genes essential for spermatogenesis

Study uncovers new genetic variants for lung cancer risk

Scientists reveal role of cellular prion protein in development of NF2-related tumors

UCLA study: Changes in brain regions may hold key to why some people prefer order and certainty

New Cornell discovery could lead to effective treatment for tuberculosis

Researchers identify fasting plasma glucose and insulin as key biomarkers for weight loss

QUT researchers develop golden-orange bananas rich in pro-vitamin A

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging